Mattila Tiina, Vasankari Tuula, Herse Fredrik, Leskelä Riikka-Leena, Erhola Marina, Avellan-Hietanen Heidi, Toppila-Salmi Sanna, Haahtela Tari
Department of Pulmonary Diseases, Heart and Lung Center, Helsinki University Hospital and Helsinki University, Meilahti Triangle Hospital, 6th floor, PO Box 372, 00029 HUS, Helsinki, Finland; Finnish Institute for Health and Welfare, PO Box 30, 00271, Helsinki, Finland.
University of Turku, Department of Pulmonary Diseases and Clinical Allergology, PO Box 52, 20521, Turku, Finland; Finnish Lung Health Association (FILHA), Sibeliuksenkatu 11 A 1, 00250, Helsinki, Finland.
Respir Med. 2023 Dec;220:107477. doi: 10.1016/j.rmed.2023.107477. Epub 2023 Nov 22.
Caring for ageing populations creates new challenges for society. Obstructive pulmonary diseases, asthma and especially COPD, are responsible for considerable morbidity, mortality, and financial costs in the elderly. We present the change in the burden of asthma and COPD in those aged ≥60 years in Finland from 1996 to 2018.
We collected national register data from 1996 to 2018 from Statistics Finland, Care Register for Health Care, and the Social Insurance Institution. We estimated the prevalence of asthma and severe COPD, use of healthcare, social services, reimbursed inhalation medications, and societal costs.
In subjects aged ≥60 years, the prevalence was 8% for asthma with reimbursed medication and 0·7% for severe COPD in 2018. In 1996-2018, total costs increased from 33 M€ to 58 M€ (+57%) for asthma and decreased from 38 M€ to 30 M€ (-27%) for COPD. Costs per patient decreased for asthma from 720 € to 460 € (-57%) and remained stable for COPD (2700 € in 2018). Potential years of life lost (PYLL) increased in COPD from 5000 to 6400 (+28%) and the number of emergency department visits increased from 3700 to 6000 (+62%).
In a population aged ≥60 years, the total burden caused by asthma decreased but remained stable and high in COPD. PYLL and visits in emergency care increased in COPD.
照顾老年人群给社会带来了新的挑战。阻塞性肺部疾病、哮喘,尤其是慢性阻塞性肺疾病(COPD),在老年人中导致了相当高的发病率、死亡率和经济成本。我们呈现了1996年至2018年芬兰60岁及以上人群中哮喘和慢性阻塞性肺疾病负担的变化。
我们从芬兰统计局、医疗保健护理登记处和社会保险机构收集了1996年至2018年的国家登记数据。我们估计了哮喘和重度慢性阻塞性肺疾病的患病率、医疗保健使用情况、社会服务、吸入药物报销情况以及社会成本。
在60岁及以上的人群中,2018年有药物报销的哮喘患病率为8%,重度慢性阻塞性肺疾病患病率为0.7%。在1996 - 2018年期间,哮喘的总成本从3300万欧元增加到5800万欧元(增长57%),慢性阻塞性肺疾病的总成本从3800万欧元下降到3000万欧元(下降27%)。哮喘患者的人均成本从720欧元降至460欧元(下降57%),慢性阻塞性肺疾病的人均成本保持稳定(2018年为2700欧元)。慢性阻塞性肺疾病的潜在寿命损失年数(PYLL)从5000增加到6400(增长28%),急诊科就诊次数从3700增加到6000(增长62%)。
在60岁及以上人群中,哮喘造成的总负担有所下降,但慢性阻塞性肺疾病的负担保持稳定且较高。慢性阻塞性肺疾病的潜在寿命损失年数和急诊科就诊次数有所增加。